ClearPoint Neuro Inc vs Twist Bioscience Corp — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 17× ClearPoint Neuro Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | TWST | |
|---|---|---|
Market Cap | $454.21M | $7.72B |
Sector | Health | Health |
52-Week High | $29.60 | $124.88 |
52-Week Low | $8.66 | $24.16 |
Enterprise Value | $488.79M | $7.65B |
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →